PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
13-Nov-2023 Thermo Fisher Scientific Opens Customer Experience Center for Battery Manufacturing in Seoul Businesswire
13-Nov-2023 Vir Biotechnology to Present New Data from Its Ongoing Phase 2 Chronic Hepatitis Delta and B Trials Today at AASLD’s The Liver Meeting® 2023 Businesswire
13-Nov-2023 Ankyra Therapeutics Announces Clinical Trial Supply Agreement with Regeneron to Evaluate ANK-101 in Combination with Libtayo® (cemiplimab) in Patients with Cutaneous Squamous Cell Carcinoma Businesswire
13-Nov-2023 Teva and Royalty Pharma Collaborate to Further Accelerate Olanzapine LAI Program Businesswire
13-Nov-2023 Alzamend Neuro Submits IND Application for a Phase IIA Clinical Trial in Post-Traumatic Stress Disorder Patients of Next‑Generation Lithium Therapeutic Drug Candidate AL001 Businesswire
13-Nov-2023 Astria Therapeutics Reports Third Quarter Financial Results and Provides a Corporate Update Businesswire
13-Nov-2023 Syngenta Group Announces Mary-Dell Chilton Awarded National Medal of Technology and Innovation Businesswire
13-Nov-2023 $7.3+Bn Emphysema Treatment Market to Grow at 5% CAGR, Globally, by 2031 The Wire Times
13-Nov-2023 $8.5+ Bn Laboratory Informatics Market to Grow at 9.2% CAGR, Globally, by 2032 The Wire Times
13-Nov-2023 NEUPATH HEALTH ANNOUNCES SUCCESSFUL CLOSING OF UPDATED CREDIT FACILITY Businesswire
13-Nov-2023 $38.9+ Bn Teledermatology Market to Grow at 15.2% CAGR, Globally, by 2032 The Wire Times
13-Nov-2023 Precision BioSciences Presents Late-Breaking Data Highlighting Preclinical Efficacy and Safety of PBGENE-HBV for Chronic Hepatitis B at AASLD’s The Liver Meeting 2023 Businesswire
13-Nov-2023 Enanta Pharmaceuticals to Host Conference Call on November 20 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal Fourth Quarter and Full Year Ended September 30, 2023 Businesswire
13-Nov-2023 Antibe Reports Q2 2024 Interim Financial and Operating Results Businesswire
13-Nov-2023 Incendia Therapeutics Appoints Wendye Robbins, M.D., as Chief Executive Officer and Doses First Patient in Phase 1b Clinical Trial of PRTH-101, a Novel DDR1 Inhibitor Businesswire
13-Nov-2023 Abcuro Initiates Part B of Registrational Phase 2/3 MUSCLE Clinical Trial of Ulviprubart (ABC008) for the Treatment of Inclusion Body Myositis Businesswire
13-Nov-2023 $6.8+Bn Hospital Capacity Management Solution Market to Grow at 8.7% CAGR, Globally, by 2031 The Wire Times
13-Nov-2023 Zura Bio Reports Third Quarter 2023 Financial Results and Recent Business Highlights Businesswire
13-Nov-2023 KalVista Pharmaceuticals Announces Phase 3 KONFIDENT Trial Milestone Achieved Businesswire
13-Nov-2023 $2,269.63+ Million Shockwave Therapy Market to Grow at 6.8% CAGR, Globally, by 2031 The Wire Times